Proximagen agreed to bid by Upsher-Smith

US pharmaceuticals firm Upsher-Smith Laboratories (USL) is making an agreed bid for UK neuroscience research firm Proximagen.

US pharmaceuticals firm Upsher-Smith Laboratories (USL) is making an agreed bid for UK neuroscience research firm Proximagen.

Under the agreement, Proximagen shareholders will receive 320p in cash for each Proximagen share, as well as a further 192p in cash or loan notes by way of a contingent value right (CVR).

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
MoneyWeek

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.